We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

11 hedge funds and large institutions have $73.4M invested in Bicycle Therapeutics in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $66.8M → $73.4M (+$6.67M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.48% less ownership

Funds ownership: 37.49% → 36.01% (-1.5%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

27% less funds holding

Funds holding: 15 → 11 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
11
Holders Change
-4
Holders Change %
-26.67%
% of All Funds
0.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
–
Increased
3
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Aquilo Capital Management
California
+$253K
2
BCM
BlueCrest Capital Management
Jersey
+$180K
3
TRCT
Tower Research Capital (TRC)
New York
+$782

Top Sellers

Rank Fund Capital Flow
1
PC
Polar Capital
United Kingdom
-$1.31M
2
MIM
Monashee Investment Management
Massachusetts
-$532K
3
Norges Bank
Norges Bank
Norway
-$176K
4
Millennium Management
Millennium Management
New York
-$160K
5
LCM
Laurion Capital Management
New York
-$80.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tybourne Capital Management
Hong Kong
$22.3M – – –
SHI
2
SV Health Investors
Massachusetts
$21.8M – – –
AVA
3
Atlas Venture Advisors
Massachusetts
$15.5M – – –
ACM
4
Aquilo Capital Management
California
$8.74M +$253K +29,497 +4%
Victory Capital Management
5
Victory Capital Management
Texas
$1.59M – – –
BCM
6
BlueCrest Capital Management
Jersey
$1.04M +$180K +20,986 +30%
LCM
7
Laurion Capital Management
New York
$1.03M -$80.4K -9,366 -9%
PCM
8
Pentwater Capital Management
Florida
$657K -$52.7K -6,135 -10%
Millennium Management
9
Millennium Management
New York
$396K -$160K -18,591 -35%
Norges Bank
10
Norges Bank
Norway
$336K -$176K -20,472 -41%
TRCT
11
Tower Research Capital (TRC)
New York
$1K +$782 +91 +9,100%
PC
12
Polar Capital
United Kingdom
– -$1.31M -130,000 Closed
MIM
13
Monashee Investment Management
Massachusetts
– -$532K -52,900 Closed
UBS Group
14
UBS Group
Switzerland
– -$17K -1,718 Closed
CCA
15
Catalyst Capital Advisors
New York
– -$5K -460 Closed

BCYC Hedge Fund Activity: Q3 2019 in Review

11 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q3 2019, worth a combined $73.4M — up 10% from $66.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BCYC and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Aquilo Capital Management, adding an estimated $253K. The largest seller was Polar Capital, exiting entirely with an estimated $1.31M sold.

  • 11 institutional investors held Bicycle Therapeutics (BCYC) as of Q3 2019, down from 15 in Q2 2019.
  • Funds reported $73.4M of Bicycle Therapeutics stock for Q3 2019, up 10% quarter-over-quarter.
  • 0 funds opened new Bicycle Therapeutics positions in Q3 2019 and 4 closed out, a net change of -4 holders.
  • The largest Bicycle Therapeutics buyer in Q3 2019 was Aquilo Capital Management, an estimated $253K added.
  • The largest Bicycle Therapeutics seller in Q3 2019 was Polar Capital, an estimated $1.31M sold.

Based on aggregated 13F filings for Q3 2019.